hydroxylamine and 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid

hydroxylamine has been researched along with 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis-Bruno, K; Halushka, PV; Schrör, K	1

Other Studies

1 other study(ies) available for hydroxylamine and 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid

Article	Year
Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine. Biochemical pharmacology, 1995, Mar-30, Volume: 49, Issue:7 Topics: Blood Platelets; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Diethyl Pyrocarbonate; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Humans; Hydrogen-Ion Concentration; Hydroxylamine; Hydroxylamines; Radioligand Assay; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2	1995

Article

Year

Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.

Biochemical pharmacology, 1995, Mar-30, Volume: 49, Issue:7

Topics: Blood Platelets; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Diethyl Pyrocarbonate; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Humans; Hydrogen-Ion Concentration; Hydroxylamine; Hydroxylamines; Radioligand Assay; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2

1995